Evidence map›Paper›PMID 25080338›Full record

ArticlePloS one2014

Novel compound heterozygous mutations in MYO7A Associated with Usher syndrome 1 in a Chinese family.

Xue Gao, Guo-Jian Wang, Yong-Yi Yuan, Feng Xin, Ming-Yu Han, Jing-Qiao Lu, Hui Zhao, Fei Yu, Jin-Cao Xu, Mei-Guang Zhang and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A Missense Mutation inBioMed research international · 2018
    Article
  6. Article
  7. Novel Mutations and Mutation Combinations ofBioMed research international · 2017
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Xue GaoDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China; Department of Otolaryngology, Hainan Branch of PLA General Hospital, Sanya, P. R. China; Department of Otolaryngology, the Second Artillery General Hospital, Beijing, P. R. China.
Guo-Jian WangDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China; Department of Otolaryngology, Hainan Branch of PLA General Hospital, Sanya, P. R. China.
Yong-Yi YuanDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China.
Feng XinDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China.
Ming-Yu HanDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China; Department of Otolaryngology, Hainan Branch of PLA General Hospital, Sanya, P. R. China.
Jing-Qiao LuDepartment of Otolaryngology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Hui ZhaoDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China; Department of Otolaryngology, Hainan Branch of PLA General Hospital, Sanya, P. R. China.
Fei YuDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China.
Jin-Cao XuDepartment of Otolaryngology, the Second Artillery General Hospital, Beijing, P. R. China.
Mei-Guang ZhangDepartment of Otolaryngology, the Second Artillery General Hospital, Beijing, P. R. China.
Jiang DongXi'an Research Institute of Hi_tech, Hongqing, Xi'an, Shaanxi, P. R. China.
Xi LinDepartment of Otolaryngology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Pu DaiDepartment of Otolaryngology, Head and Neck Surgery, PLA General Hospital, Beijing, P. R. China; Department of Otolaryngology, Hainan Branch of PLA General Hospital, Sanya, P. R. China.
Chinese PLA General Hospital · CNEmory University · USHainan Branch of People's Liberation Army General Hospital · CNSecond Artillery General Hospital of Chinese People's Liberation Army · CNMicrobiology Institute of Shaanxi · CN

Funding

Genetic hearing screening and diagnosis facilitated by using a combined low-costR33DC010476 · NIDCD · EMORY UNIVERSITY · PI LIN, XI · 2010 to 2013
$2.0M
Impact of Prenatal Alcohol Exposure on Receptor Targeting and FunctioningR03AA020101 · NIAAA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CALDWELL, KEVIN K. · 2010 to 2011
$148k
NIAAA NIH HHS R03 AA020101NIDCD NIH HHS R33 DC010476
6 · The paper itself

Abstract

Usher syndrome is an autosomal recessive disease characterized by sensorineural hearing loss, age-dependent retinitis pigmentosa (RP), and occasionally vestibular dysfunction. The most severe form is Usher syndrome type 1 (USH1). Mutations in the MYO7A gene are responsible for USH1 and account for 29-55% of USH1 cases. Here, we characterized a Chinese family (no. 7162) with USH1. Combining the targeted capture of 131 known deafness genes, next-generation sequencing, and bioinformatic analysis, we identified two deleterious compound heterozygous mutations in the MYO7A gene: a reported missense mutation c.73G>A (p.G25R) and a novel nonsense mutation c.462C>A (p.C154X). The two compound variants are absent in 219 ethnicity-matched controls, co-segregates with the USH clinical phenotypes, including hearing loss, vestibular dysfunction, and age-dependent penetrance of progressive RP, in family 7162. Therefore, we concluded that the USH1 in this family was caused by compound heterozygous mutations in MYO7A.

Indexed as

HeterozygoteMutationAmino Acid SequenceAnimalsChinaFemaleHumansMaleMiddle AgedMolecular Sequence DataMyosinsMyosin VIIaPedigreeSequence Homology, Amino AcidUsher SyndromesMYO7A protein, humanMyosinsMyosin VIIa

Identifiers

PMID25080338
PMCPMC4117490
OpenAlexW2107579949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.